SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-045370
Filing Date
2024-11-06
Accepted
2024-11-06 11:15:52
Documents
15
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20038192_8k.htm   iXBRL 8-K 28058
2 EXHIBIT 99.1 ef20038192_ex99-1.htm EX-99.1 418591
6 image0.jpg GRAPHIC 24775
  Complete submission text file 0001140361-24-045370.txt   643874

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20241106.xsd EX-101.SCH 3973
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20241106_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20241106_pre.xml EX-101.PRE 16038
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20038192_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 241429699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)